Research
A Pilot Study: Consumptions of Statins in Morocco and North Cyprus
Author(s): Khalid EL Hassouni and Hurmus Refiker*
Background: Cholesterol lowering drugs, statins, are a major and dominant group of hypolipidemics and are often
prescribed in clinical practice for the prevention and treatment of cardiovascular diseases. Objective: To assess
the consumption of statins, more specifically rosuvastatin, atorvastatin and simvastatin in two different countries;
Morocco and North Cyprus.
Setting: The study was conducted in Pharmacy Kounouz, Rabat, Morocco and Pharmacy
Umut ÖKSÜZ in Nicosia North Cyprus. During the period of November, December 2018 and January 2019.
Method:
This study involves a sample of 100 patients of pharmacy Kounouz, Rabat Morocco and Pharmacy Umut ÖKSÜZ,
Nicosia, North Cyprus, who were on regular therapy with statins (Atorvastatin, Simvastatin or Rosuvastatin) in the
mentio.. Read More»
Select your language of interest to view the total content in your interested language